The Enterprise Value as of September 2024 (TTM) for PolyPid Ltd. (PYPD) is 31.37M

According to PolyPid Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 31.37M. This represents a change of 39.69% compared to the average of 22.45M of the last 4 quarters.

PolyPid Ltd. (PYPD) Historical Enterprise Value (quarterly & annually)

How has PYPD Enterprise Value performed in the past?

The mean historical Enterprise Value of PolyPid Ltd. over the last ten years is 139.18M. The current 31.37M Enterprise Value has changed 2.15% with respect to the historical average. Over the past ten years (40 quarters), PYPD's Enterprise Value was at its highest in in the December 2017 quarter at 319.98M. The Enterprise Value was at its lowest in in the June 2014 quarter at -4029000.00.

PolyPid Ltd. (PYPD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PolyPid Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PolyPid Ltd. (PYPD) Average Enterprise Value

How has PYPD Enterprise Value performed in the past?

The current Enterprise Value of PolyPid Ltd. (PYPD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PolyPid Ltd. (PYPD) Enterprise Value vs. Peers

How is PYPD’s Enterprise Value compared to its peers?

PolyPid Ltd.’s Enterprise Value is greater than Cue Biopharma, Inc. (8.60M), less than Anixa Biosciences, Inc. (105.53M), less than INmune Bio, Inc. (80.30M), greater than IN8bio, Inc. (10.38M), greater than eFFECTOR Therapeutics, Inc. (3.86M), less than Landos Biopharma, Inc. (42.62M), greater than Apexigen, Inc. (205.32K), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), greater than Angion Biomedica Corp. (22.43M), less than Anebulo Pharmaceuticals, Inc. (49.05M), less than Armata Pharmaceuticals, Inc. (198.98M), greater than Virpax Pharmaceuticals, Inc. (1.94M), less than Vaccitech plc (45.13M), greater than Virax Biolabs Group Limited (8.88M), greater than Blue Water Vaccines, Inc. (8.67M), greater than Revelation Biosciences, Inc. (-10594336.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kiora Pharmaceuticals, Inc. (3.77M), less than Pyxis Oncology, Inc. (207.70M), less than Zura Bio Limited (40.51M), greater than Altamira Therapeutics Ltd. (889.48K), greater than Elevation Oncology, Inc. (7.75M),

Build a custom stock screener for PolyPid Ltd. (PYPD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PolyPid Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PolyPid Ltd. (PYPD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PolyPid Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.